Ionis Pharmaceuticals, Inc.
CONJUGATED ANTISENSE COMPOUNDS AND THEIR USE

Last updated:

Abstract:

Provided herein are oligomeric compounds comprising a modified oligonucleotide and a conjugate group for modulating the amount or activity of a target nucleic acid in extra hepatic tissues and extra hepatic cells. Also provided herein are methods of modulating the amount or activity of an extra-hepatic nucleic acid target in a cell comprising contacting the cell with the oligomeric compound or antisense compound.

Status:
Application
Type:

Utility

Filling date:

26 Sep 2016

Issue date:

25 Feb 2021